Home » Stocks » DarioHealth

DarioHealth Corp. (DRIO)

Stock Price: $16.30 USD 1.60 (10.88%)
Updated Aug 13, 2020 4:00 PM EDT - Market closed
After-hours: $16.00 -0.30 (-1.84%) Aug 13, 7:34 PM

Stock Price Chart

Key Info

Market Cap 61.83M
Revenue (ttm) 6.98M
Net Income (ttm) -20.88M
Shares Out 7.21M
EPS (ttm) -10.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 13, 2020
Last Price $16.30
Previous Close $14.70
Change ($) 1.60
Change (%) 10.88%
Day's Open 15.48
Day's Range 15.00 - 16.65
Day's Volume 191,523
52-Week Range 3.02 - 18.84

More Stats

Market Cap 61.83M
Enterprise Value 49.08M
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 7.21M
Float 2.82M
EPS (basic) -5.85
EPS (diluted) -10.35
FCF / Share -3.27
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 6,415
Short Ratio 0.07
Short % of Float 0.36%
Beta 0.90
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 8.85
PB Ratio 4.42
Revenue 6.98M
Operating Income -21.22M
Net Income -20.88M
Free Cash Flow -13.49M
Net Cash 12.75M
Net Cash / Share 3.36
Gross Margin 37.18%
Operating Margin -303.79%
Profit Margin -366.50%
FCF Margin -193.10%
ROA -89.20%
ROE -230.70%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$13.25*
(-18.71% downside)
Low
8.00
Current: $16.30
High
25.00
Target: 13.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue7.567.395.172.800.820.05--
Revenue Growth2.23%43.02%84.45%240.58%1513.73%---
Gross Profit2.601.771.31-0.83-0.86-2.71--
Operating Income-17.71-17.69-14.42-11.10-7.70-11.36-13.56-3.97
Net Income-17.74-17.80-15.74-10.90-7.14-12.88-13.93-5.69
Shares Outstanding2.271.170.480.260.090.020.010.01
Earnings Per Share-8.00-15.63-32.80-41.80-76.80-666.00-1,367.89-827.93
Operating Cash Flow-15.73-11.47-10.62-8.38-6.28-8.58-7.60-2.98
Capital Expenditures-0.10-0.07-0.20-0.81-0.11-0.56-1.40-0.53
Free Cash Flow-15.82-11.54-10.81-9.19-6.39-9.14-9.00-3.52
Cash & Equivalents20.5911.223.981.322.751.542.461.27
Total Debt0.77-------
Net Cash / Debt19.8111.223.981.322.751.542.461.27
Assets24.5714.096.963.875.083.084.122.32
Liabilities5.685.163.0210.416.668.384.203.38
Book Value18.898.933.94-6.54-1.58-5.30-0.09-1.07
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name DarioHealth Corp.
Country Israel
Employees 62
CEO Erez Raphael

Stock Information

Ticker Symbol DRIO
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: DRIO

Description

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Blood Glucose Monitoring System, a pocket-sized, blood glucose monitoring device. It offers DarioEngage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications; and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy, hospitals, and distributors; and through online. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.